NCT06524440

Brief Summary

In this Cross-sectional study, we will analyzed data from a tertiary referral Congolese hospital to find whether or not Congolese patients with hypertensive heart disease have multiple comorbid conditions. Will report on the management and outcomes of the patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 24, 2024

Completed
2 days until next milestone

Study Start

First participant enrolled

July 26, 2024

Completed
2 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 28, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 29, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 29, 2024

Completed
Last Updated

July 29, 2024

Status Verified

July 1, 2024

Enrollment Period

2 days

First QC Date

July 24, 2024

Last Update Submit

July 24, 2024

Conditions

Hypertensive Heart Disease

Keywords

ComorbiditiesDemocratic Republic of CongoHypertensive heart diseaseManagement

Outcome Measures

Primary Outcomes (1)

  • High Systolic Blood Pressure

    The study will use high systolic blood pressures as a measure for hypertensive heart disease.

    1 month

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients 18 year or older diagnosed with hypertensive heart disease at Monkole Mother and Infant Hospital Center from January to December 2019

You may qualify if:

  • Patients is 18 year or older
  • Patient is diagnosed with hypertensive heart disease

You may not qualify if:

  • Patient is not 18 year or older
  • Patient is not diagnosed with hypertensive heart disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Monkole Mother and Infant Hospital Center

Kinshasa, Democratic Republic of the Congo

RECRUITING

Study Officials

  • Raïssa K Kongue, MD

    Faculty of Medicine, Bel Campus University of Technology, Kinshasa, Democratic Republic of Congo

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ulrick S Kanmounye, MD(c)

CONTACT

781 658 4443ulricksidney@gmail.com

Jonathan A Nuamah, MD(c)

CONTACT

(0)203701316jonathan.a.nuamah@gmail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 24, 2024

First Posted

July 29, 2024

Study Start

July 26, 2024

Primary Completion

July 28, 2024

Study Completion

July 29, 2024

Last Updated

July 29, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will share

The IPD from this study will be openly available in the Open Science Framework.

Time Frame
It will be indefinitely available after the study has been conducted.
Access Criteria
This data will be open to all individuals.
More information

Locations

DE(1)